Abstract:High salt intake is the leading dietary risk factor for hypertension. Although clinical evidence suggests that high salt intake is associated with non-alcoholic fatty liver disease (NAFLD) that is an independent risk factor for hypertension, it remains elusive whether salt-induced hepatic damage leads to the development of hypertension. SIRT3 is the main protector in liver metabolism, and knockout of SIRT3 in mice results in fatty liver and metabolic syndrome. Therefore, we asked whether SIRT3 in liver participated in salt-induced hypertension and investigated the underlying mechanism. 6-week male wild-type or SIRT3-knockout (SIRT3−/−) mice were fed with 0.4% normal salt diet (NSD) or 8% high salt diet (HSD) for 16 weeks. Liver weight, body weight and blood pressure were measured. H&E, Oil-O red, and Sirius Red staining were performed on liver frozen sections to detect steatosis, lipid accumulation and fibrosis, respectively. Hepatic inflammation was reflexed by immunofluorescent staining of Cd11b, Mpo and F4/80, the markers of neutrophils, macrophages and Kupffer cells, respectively. Adeno-associated virus 8 (AAV8) with a Thyroxine-Binding Globulin (TBG) promoter was used to overexpress SIRT3 in liver. Chromatin immunoprecipitation sequencing (ChIP-seq) with an antibody against acetylated histone 3 lysine 27 (H3K27ac), an activated promoter marker, was used to explore the possible mechanism underlying the effect of SIRT3 on salt-induced hepatic inflammation. HSD induced a significant increase in systolic blood pressure, a higher liver weight to body weight ratio, and stimulated lipid accumulation, steatosis, and fibrosis in the liver, accompanied by a lowered expression of SIRT3 in liver. Knockout of SIRT3 further exacerbated HSD-induced hepatic steatosis and inflammation, resulting in a more severe hypertension. Restoration of hepatic SIRT3 expression in SIRT3−/− mice by injection of AAV8-TBG-SIRT3 lowered all these pathological changes induced by HSD. ChIP-seq results suggest that knockout of SIRT3 mainly affected the H3K27ac level of promoters of genes related to AMP-activated protein kinase (AMPK) and insulin signaling pathways. Activation of AMPK by metformin significantly blocked salt-induced hepatic inflammation and hypertension, accompanied with an elevated SIRT3 expression in liver. The present study proves that the reduced SIRT3 expression in liver plays a critical role in salt-induced hypertension by inducing hepatic inflammation. Restoration of hepatic SIRT3 expression or treatment with metformin helps to stave off hepatic inflammation that underlies salt-induced hypertension in clinical practice.

SIRT3/AMPK signaling pathway regulates lipid metabolism and improves vulnerability to atrial fibrillation in Dahl salt sensitive rats

High-Salt Diet Inhibits the Expression of Bmal1 and Promotes Atrial Fibrosis and Vulnerability to Atrial Fibrillation in Dahl Salt-Sensitive Rats

SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-β1/Smad2/3 signalling pathway

S-08-2: RESTORATION OF SIRT3 EXPRESSION IN LIVER ALLEVIATES HIGH-SALT-INDUCED HYPERTENSION

Abstract P3016: Role Of AMPK/Sirtuin3 Signaling In HFpEF-associated Atrial Myopathy

Honokiol Inhibits Atrial Metabolic Remodeling in Atrial Fibrillation Through Sirt3 Pathway

Salt-Induced Hepatic Inflammatory Memory Contributes to Cardiovascular Damage Through Epigenetic Modulation of SIRT3

Salidroside treatment decreases the susceptibility of atrial fibrillation in diabetic mice by reducing mTOR-STAT3-MCP-1 signaling and atrial inflammation

Hydrogen Sulfide Ameliorates Angiotensin II-Induced Atrial Fibrosis Progression to Atrial Fibrillation Through Inhibition of the Warburg Effect and Endoplasmic Reticulum Stress

Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway

SGLT2i alleviates epicardial adipose tissue inflammation by modulating ketone body-glyceraldehyde-3-phosphate dehydrogenase malonylation pathway

AMPK attenuates ventricular remodeling and dysfunction following aortic banding in mice via the Sirt3/Oxidative stress pathway

Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression

S-Methyl-L-cysteine targeting MsrA attenuates Ang II-induced oxidative stress and atrial remodeling via the p38 MAPK signaling pathway

Resveratrol mediates mitochondrial function through the sirtuin 3 pathway to improve abnormal metabolic remodeling in atrial fibrillation

Chronic stimulation of the sigma-1 receptor ameliorates autonomic nerve dysfunction and atrial fibrillation susceptibility in a rat model of depression

The Sirtuin 6 Prevents Angiotensin II-mediated Myocardial Fibrosis and Injury by Targeting AMPK-ACE2 Signaling

Chronic Inhibition of the Sigma-1 Receptor Exacerbates Atrial Fibrillation Susceptibility in Rats by Promoting Atrial Remodeling.

A10747 Effects of High Salt Intake on Blood Pressure and the Expression of Adiponectin and AMPK in SD Rats

High-Salt Intake Suppressed Microrna-133a Expression In Dahl Ss Rat Myocardium

Halofuginone ameliorates the susceptibility to atrial fibrillation by activating the PI3K/Akt signaling pathway